Mike Minogue is running for the governorship of Massachusetts, while Johnson & Johnson purchased Abiomed in 2022 for $17 billion.

2 reports, 2 independent Updated Sep 6

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Mike Minogue is running for the governorship of Massachusetts, while Johnson & Johnson purchased Abiomed in 2022 for $17 billion.

Who's involved

What this event is mainly about

Massachusetts Johnson & Johnson

Keep exploring

Part of

Abiomed is a medical device company, Maura Healey serves as the current office holder, and Mike Minogue is a candidate for state office in Massachusetts. All 2 developments

The entities involved

Massachusetts
state of the United States of America
- Governor Maura Healey manages state policy challenges in Massachusetts.Mon 13:03
- An unnamed entity (T) is considering Keolis for a new contract in Massachusetts, while also warning about economic operational risks and providing advisory on operational costs.Mon 10:57
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
- P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04

Related events

Coverage

Newest first; wire copies grouped

Sep 6bostonherald.com
Sep 1boston.com